Job purpose:

Reporting to the Evidence Strategy & Operations Lead, this role operates across therapeutic areas to deliver payer‑focused evidence generation, drive HEOR activities for priority assets.  The role has a strong HTA focus and will drive HTA submission projects, prioritising evidence packages and dossier development to meet local HTA and reimbursement requirements; coordinate evidence generation, modelling and stakeholder engagement; and provide HTA‑specific scientific and strategic input to secure favourable access outcomes.



Key Responsibilities:

Evidence synthesis & health economics

Lead health economics projects to generate high quality and timely data to support the access of prioritised brands to the Japan market, including leading and executing evidence synthesis activities: systematic literature reviews (SLRs), targeted literature reviews (TLRs) and meta-analyses to support HTA, economic models and payer evidence needs.

Responsible for the development and delivery of Japan health technology assessment (HTA) submissions including development and agreement of strategy, liaison with internal and external senior stakeholders and the reimbursement bodies.

Input into pricing decisions for brands to ensure that cost effectiveness is appropriately considered in decision making.

Collaborate with Asset Leads in Japan and Global Real-World Evidence & Health Outcomes Research (RWE-HO), local cross-functional teams, including Government Affairs & Market Access (GAMA), regulatory and development to ensure payer/ value evidence are developed with a full understanding of the requirements of Japan health system/ policy landscape.



Capability building & stakeholder engagement

Build relationships with HTA bodies, payer advisors, clinical experts, and academic institutions to ensure external relevance and scientific credibility.

Monitor healthcare policy, HTA trends, and competitive landscape to inform proactive evidence planning.

Drive discipline in performance reporting and ensure studies are delivered according to plan and within budget.

Champion the role and value of HEOR internally, increasing understanding across functions on how evidence supports access and adoption.